Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation

Johnston, R; Uthman, O; Cummins, E; Clar, C; Royle, P; Colquitt, J; Tan, BK; Clegg, A; Shantikumar, S; Court, R; O'Hare, JP; McGrane, D; Holt, T; Waugh, N

Waugh, N (reprint author), Univ Warwick, Div Hlth Sci, Warwick Evidence, Coventry, W Midlands, England.

HEALTH TECHNOLOGY ASSESSMENT, 2017; 21 (2): 1

Abstract

Background: Most people with type 2 diabetes are overweight, so initial treatment is aimed at reducing weight and increasing physical activity. Even m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索